261 related articles for article (PubMed ID: 20694948)
1. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
3. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
4. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
Haider MA; van der Kwast TH; Tanguay J; Evans AJ; Hashmi AT; Lockwood G; Trachtenberg J
AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
[TBL] [Abstract][Full Text] [Related]
7. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
8. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization.
Rosenkrantz AB; Mannelli L; Kong X; Niver BE; Berkman DS; Babb JS; Melamed J; Taneja SS
J Magn Reson Imaging; 2011 Jul; 34(1):95-100. PubMed ID: 21698707
[TBL] [Abstract][Full Text] [Related]
11. Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis.
Li B; Cai W; Lv D; Guo X; Zhang J; Wang X; Fang J
J Magn Reson Imaging; 2013 Jan; 37(1):194-200. PubMed ID: 23002033
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient for prostate cancer imaging: impact of B values.
Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A
AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
[TBL] [Abstract][Full Text] [Related]
15. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.
Kim CK; Choi D; Park BK; Kwon GY; Lim HK
J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
19. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
Kim JH; Kim JK; Park BW; Kim N; Cho KS
J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder.
Lee NK; Kim S; Kim TU; Kim DU; Seo HI; Jeon TY
Clin Radiol; 2014 Feb; 69(2):e78-85. PubMed ID: 24290779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
